The HeartShare study aims to better understand heart failure, a condition where your heart can't pump enough blood, causing symptoms like shortness of breath and tiredness. Researchers want to classify heart failure into different types to help create more personalized treatments for patients. This study is observational, meaning it will gather information from existing records and new participants, rather than testing a specific drug. They are looking for 1000 participants, including those with a previous heart failure diagnosis and those without, all aged 30 or older. The main goal is to count how many participants have a specific type of heart failure called Heart Failure with Preserved Ejection Fraction (HFpEF) over a period of up to 5 years.

Study design

This is an observational study aiming to enroll 1000 participants. It is not testing a specific treatment.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for up to 5 years to measure the number with Heart Failure with Preserved Ejection Fraction (HFpEF).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.